PER 1.27% 8.0¢ percheron therapeutics limited

Ann: Positive feedback received on Paediatric Investigation Plan, page-32

ANNOUNCEMENT SPONSORED BY PLUS500
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM
CFD Service. Your Capital is at risk
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
ANNOUNCEMENT SPONSORED BY PLUS500
CFD TRADING PLATFORM CFD Service. Your Capital is at risk
  1. 4,710 Posts.
    lightbulb Created with Sketch. 1097
    Nice report once again from Dr Shane Storey.

    Re previous discussions this week about Capricor's P2 results - here is the informed opinion

    ANP has superior efficacy over Capricor.

    "......This compares to a potential 2.9 point advantage for ATL1102 when using a proxy historical matched control cohort in absence of a placebo arm. Even with the +7 outlier removed we assess a superior advantage for ATL1102 (2.13 point). "

    ZZZZ ANP.jpg
 
watchlist Created with Sketch. Add PER (ASX) to my watchlist
(20min delay)
Last
8.0¢
Change
0.001(1.27%)
Mkt cap ! $82.94M
Open High Low Value Volume
8.0¢ 8.3¢ 7.9¢ $461.5K 5.711M

Buyers (Bids)

No. Vol. Price($)
6 844186 8.0¢
 

Sellers (Offers)

Price($) Vol. No.
8.2¢ 292500 1
View Market Depth
Last trade - 16.10pm 08/11/2024 (20 minute delay) ?
PER (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.